What this means
This is a plan for a study that has not started collecting results yet. It aims to compare allergic and eosinophilic asthma patients on breathing, symptoms and frailty.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 35–75
- Where
- 1 site
The science
- Registered title
- Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics
- Trial ID
- NCT06796894 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Asthma, Respiratory Disease, Fragility
- Sponsor
- Hacettepe University
- Ages
- 35 Years to 75 Years
- Dates
- First posted Jan 28, 2025 · updated Dec 29, 2025
Registry summary
The aim of this study is to determine the level of respiratory dysfunction, symptoms and frailty in patients with asthma according to different endophenotypes (allergic and eosonophilic asthma). In the light of the data obtained, it is thought that rehabilitation approaches that can be determined according to different endophenotypes in line with the evaluated parameters will guide health professionals working in this field.
Hypotheses H0: There is no difference between allergic and eosonophilic asthmatics in terms of pulmonary function, respiratory dysfunction, symptoms, dyspnoea, fatigue, rhinitis, perception of breathlessness in activities of daily living, asthma control, level of frailty or quality of life.
H1: There is a difference between individuals with allergic and eosonophilic asthma in terms of pulmonary function, respiratory dysfunction, symptoms, dyspnoea, fatigue, rhinitis, perception of breathlessness in activities of daily living, asthma control, level of frailty or quality of life.
Sites (1)
- Hacettepe University, Ankara, State, Turkey (Türkiye)